US approves two gene therapies for sickle cell disease
The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, making one of them the first treatment in the United States based on the Nobel Prize-winning CRISPR gene editing technology.
Researchers help stroke survivors walk again
More than half of stroke survivors aged 65 and over have problems moving their bodies, according to the CDC. Syracuse University in New York is using robotics in a rehabilitation setting to give people their movement back.
U.S life expectancy has first rise since COVID
After years of dramatic decline in life expectancy in the United States, there's finally some good news. Emory University's Dr. Neil Winawer discusses the new data showing a slight jump in life expectancy.
EU seeks more data from GLP-1 drugmakers on suicidal thoughts
The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs, including Novo Nordisk's popular therapies Ozempic and Wegovy, to further investigate suicidal thoughts in some patients taking them.
Scientists work to 3D bioprint a human heart in 5 years
A team of Stanford University engineers, cardiologists, and biology experts are at work to bioprint a fully functioning human heart to implant into a pig.
Acupuncture may enhance post-surgery outcomes in cardiac patients
The future of post-op heart surgery getting that patient from the hospital bed back home safely and quickly could soon start to involve traditional eastern medicine like acupuncture.
UK approves groundbreaking gene-editing therapy
A new gene-editing treatment is offering new hope for people living with the blood disorders sickle cell disease and thalassemia. Approved in Britain, there is hope the breakthrough treatment may soon be available to all.
Climate change drives Bangladesh's worst dengue outbreak
Kabirul Bashar, a professor at Jahangirnagar University in the capital Dhaka, has spent the good part of his career studying mosquitoes, hoping to find ways to prevent the spread of mosquito-borne diseases, including dengue fever. Amid a...
Novo's Wegovy trial shows heart benefit in obesity patients
Novo Nordisk revealed details from a key study backing the use of Wegovy, its blockbuster weight-loss drug, to cut heart attacks and deaths in obesity patients with a history of cardiovascular disease.
Study finds rate of alcohol mortality rising
Alcohol-related deaths in the United States jumped by 26% from 2019 to 2020, a report published by the CDC. The increase was sharper among women ages 35 to 44, going up by 42%.
Weight loss drug Wegovy slashes risk of heart attacks, trial finds
Novo Nordisk says the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone, according to new data presented at a major medical meeting.
Surgeons perform world's first eye transplant
Surgeons in New York have performed the first-ever whole-eye transplant on a human, an accomplishment being hailed as a breakthrough even though the patient has not regained sight in the eye. Aaron James, who survived a work-related high...
Successful world first whole eye transplant
A team of surgeons in New York has performed the world's first transplant of an entire eye in a procedure widely hailed as a medical breakthrough, although it isn't yet known whether the man will ever see through the donated eye.
Swiss tech helps Parkinson's patient walk again
A long-term Parkinson's disease patient, Marc Gauthier had essentially been confined to his home until he became the first person to receive a new Swiss-designed implant that dramatically improved his ability to walk.
Novo Nordisk halts successful Ozempic trial
Novo Nordisk is halting a study which looked at the impact of its blockbuster Ozempic drug on kidney failure after it showed effectiveness surprisingly early.
Walmart says Ozempic may imact foodsales
Walmart Inc. says it's already seeing an impact on shopping demand from people taking the diabetes drug Ozempic, Wegovy and other appetite-suppressing medications.
Nobel prize to scientists who laid groundwork for COVID vaccines
The scientists who provided the foundational research that lead to mRNA vaccines — the first vaccines against COVID-19 — have won the 2023 Nobel Prize in Physiology or Medicine.
Scientists win medicine Nobel for COVID vaccine work
Hungarian Katalin Kariko and American Drew Weissman have won the 2023 Nobel Prize in Physiology or Medicine for discoveries enabling the development of mRNA COVID-19 vaccines. The duo, whose discoveries helped in the fight against the gl...
Weight-loss drugs scrutinized over reports of suicide risk
Reuters has found that some patients experience thoughts of suicide or self-harm after taking increasingly popular weight-loss drugs, such as Wegovy and Ozempic. Reports like these stood out to experts Reuters talked to, who say they war...
American Red Cross faces blood supply shortage
The end of summer usually sees a big blood supply shortage and this year is no different. The Red Cross is putting out the call for more donations.
Handheld device ‘mimics’ chest physiotherapy
British students have developed a hand-held device to help people with excess mucus breathe more easily. It combines the chest thumping of a physiotherapist to loosen mucus with artificial intelligence - and just won Britain's prestigiou...
CDC warns flesh eating bacteria on the rise
Infections from the bacteria are on the rise due to warming coastal waters, which may contribute to this warning.
U.S. pharmacies plagued with ADHD medication shortage
FOX Medical Team reporter Beth Galvin discusses the persistent shortage of ADHD medications like Adderall, its causes, potential surges in diagnoses, uncertain supply improvements, and what individuals should do if they can't obtain thei...
U.S government approves breakthrough Alzheimer’s drug
The U.S Food and Drug Administration has given full approval for a drug they say can slow the progression of Alzheimer's disease. The incurable neurological disease affects millions of people worldwide. Doctors are hopeful the drug will ...
Musk owned Neuralink approved for human trials
Elon Musk's brain-implant company Neuralink says it has received U.S regulatory approval for human trials for the first time -- a major milestone for the company after an earlier rejection reportedly over safety concerns. Musk envisions ...
Paralysed man walks again thanks to brain implant
A paralysed man has regained the ability to walk using only his thoughts thanks to new technology that restored communication between his brain and spinal cord.
Scientists develop blood test for miscarriage
The study, which has had 1,700 women participants so far, is looking to detect the cause behind a lost pregnancy as early as five weeks gestation.
'Pangenome' project: Unlocking the human genome
Researchers in the United States have improved on the Human Genome Project. They are adding 47 new samples to the map of DNA that was completed at the turn of the century. Scientists say expanding the genome library will help address ine...
First 'three parent' baby born in the UK
In the UK, a baby has been born using a new technique involving DNA from three people to help prevent the inheritance of incurable diseases.